Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion

por Chu, Quincy S.
Publicado 2020

Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer

por Daoud, Alia, Chu, Quincy S.
Publicado 2017

Present and Emerging Biomarkers in Immunotherapy for Metastatic Non-Small Cell Lung Cancer: A Review

por Khwaja, Raida M., Chu, Quincy S.-C.
Publicado 2022

Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors

por Zhang, Lei, Coffin, John, Formenti, Kim, Chu, Quincy, Izevbaye, Iyare
Publicado 2022

Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future

por Mulder, Karen, Koski, Sheryl, Scarfe, Andrew, Chu, Quincy, King, Karen, Spratlin, Jennifer
Publicado 2010

Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist

por Kazemi-Bajestani, Seyyed M. R., Becher, Harald, Fassbender, Konrad, Chu, Quincy, Baracos, Vickie E.
Publicado 2014

A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors

por McDonald, Paul C., Chia, Stephen, Bedard, Philippe L., Chu, Quincy, Lyle, Michael, Tang, Liren, Singh, Madhu, Zhang, Zaihui, Supuran, Claudiu T., Renouf, Daniel J., Dedhar, Shoukat
Publicado 2020

Rapid atrophy of cardiac left ventricular mass in patients with non‐small cell carcinoma of the lung

por Kazemi‐Bajestani, Seyyed Mohammad Reza, Becher, Harald, Butts, Charles, Basappa, Naveen S., Smylie, Michael, Joy, Anil Abraham, Sangha, Randeep, Gallivan, Andrea, Kavsak, Peter, Chu, Quincy, Baracos, Vickie E.
Publicado 2019

The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer

por Melosky, Barbara, Cheema, Parneet, Juergens, Rosalyn A., Leighl, Natasha B., Liu, Geoffrey, Wheatley-Price, Paul, Sacher, Adrian, Snow, Stephanie, Tsao, Ming-Sound, McLeod, Deanna, Chu, Quincy
Publicado 2021

Canadian Consensus Recommendations on the Management of MET-Altered NSCLC

por Cheema, Parneet K., Banerji, Shantanu O., Blais, Normand, Chu, Quincy S.-C., Desmeules, Patrice, Juergens, Rosalyn A., Leighl, Natasha B., Sheffield, Brandon S., Wheatley-Price, Paul F., Melosky, Barbara L.
Publicado 2021

Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer

por Ionescu, Diana N., Stockley, Tracy L., Banerji, Shantanu, Couture, Christian, Mather, Cheryl A., Xu, Zhaolin, Blais, Normand, Cheema, Parneet K., Chu, Quincy S.-C., Melosky, Barbara, Leighl, Natasha B.
Publicado 2022

Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience

por Rupp, Martin, Fanton-Aita, Fiorella, Snow, Stephanie, Wheatley-Price, Paul, Melosky, Barbara, Juergens, Rosalyn A., Chu, Quincy, Blais, Normand, Banerji, Shantanu, Ng, Ryan, Khoudigian, Shoghag, Sharma, Arushi, On, Phu Vinh, Liu, Geoffrey
Publicado 2023

Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer

por Wong, Selina K., Chu, Quincy S.C., Spratlin, Jennifer L., Sangha, Randeep, McEwan, Alexander J.B., Morrish, Donald W., Arndt, Diane, Sergenson, Gwen, Cleton, Adriaan, Huang, Funan, Sawyer, Michael B.
Publicado 2019

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer

por Melosky, Barbara L., Leighl, Natasha B., Dawe, David, Blais, Normand, Wheatley-Price, Paul F., Chu, Quincy S.-C., Juergens, Rosalyn A., Ellis, Peter M., Sun, Alexander, Schellenberg, Devin, Ionescu, Diana N., Cheema, Parneet K.
Publicado 2023

Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC

por Cheema, Parneet K., Banerji, Shantanu O., Blais, Normand, Chu, Quincy S.-C., Juergens, Rosalyn A., Leighl, Natasha B., Sacher, Adrian, Sheffield, Brandon S., Snow, Stephanie, Vincent, Mark, Wheatley-Price, Paul F., Yip, Stephen, Melosky, Barbara L.
Publicado 2023

Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Datab...

por Grosjean, Heidi A. I., Dolter, Samantha, Meyers, Daniel E., Ding, Philip Q., Stukalin, Igor, Goutam, Siddhartha, Kong, Shiying, Chu, Quincy, Heng, Daniel Y. C., Bebb, D. Gwyn, Morris, Don G., Cheung, Winson Y., Pabani, Aliyah
Publicado 2021

A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors

por Bauer, Todd M., Moore, Kathleen N., Rader, Janet S., Simpkins, Fiona, Mita, Alain C., Beck, J. Thaddeus, Hart, Lowell, Chu, Quincy, Oza, Amit, Tinker, Anna V., Imedio, Esteban Rodrigo, Kumar, Sanjeev, Mugundu, Ganesh, Jenkins, Suzanne, Chmielecki, Juliann, Jones, Suzanne, Spigel, David, Fu, Siqing
Publicado 2023

Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody–drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors

por Rottey, Sylvie, Clarke, Jeffrey, Aung, Kyaw, Machiels, Jean-Pascal, Markman, Ben, Heinhuis, Kimberley M., Millward, Michael, Lolkema, Martijn, Patel, Sandip Pravin, de Souza, Paul, Duca, Matteo, Curigliano, Giuseppe, Santoro, Armando, Koyama, Takafumi, Brown, Michelle, Vezina, Heather, He, Chunsheng, Chu, Quincy Siu-Chung
Publicado 2022

BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study

por Chu, Quincy, Leighl, Natasha B., Surmont, Veerle, van Herpen, Carla, Sibille, Anne, Markman, Ben, Clarke, Stephen, Juergens, Rosalyn A., Rivera, Mirelis Acosta, Andelkovic, Vladimir, Rudin, Charles M., Snow, Stephanie, Kim, Dong-Wan, Sanatani, Michael, Lin, Hongxia, Sanghavi, Kinjal, Tannenbaum-Dvir, Sarah, Basciano, Paul, Lathers, Deanne, Urbanska, Katarzyna, Kollia, Georgia, He, Chunsheng, DiPiero, Andrew, Liu, Yu, Ready, Neal
Publicado 2022